glp-1 gip 2ra GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Glucagon-Like Peptide-1 Based Therapies: A

Some individuals may experience mild digestive upset or bloating if they take high doses initially, and because it contains sulfur, a small number of people with sulfur sensitivities might experience minor reactions

Long-term clinical trials, including one that lasted four years, found no serious safety concerns at these levels.7 Most people tolerate ALA well, but some mild side effects can occur, especially at higher doses: Digestive issues like nausea, bloating, or stomach upset Skin reactions, including rash or itching Low blood sugar, especially when taken with diabetes medications These side effects are usually temporary and mild, but they appear more frequently at doses of 1,200mg/day or higher.3 4 Medication interactions ALA may interact with several medications and should be used with caution in these cases:39 Diabetes medications (e.g., insulin, metformin) ALA can help lower blood glucose, which may enhance the effects of diabetes drugs and increase the risk of hypoglycemia

This is a valuable tool to add to your weight management toolbox

Hammerich L, Tacke F

Activation of PGC1 results in greater expression of slow-twitch muscle fibers which depend on increased mitochondrial biogenesis and oxidative metabolism as a main energy source

2024;22(6):1226-37 e14